1. Home
  2. VERX vs BCRX Comparison

VERX vs BCRX Comparison

Compare VERX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Inc.

VERX

Vertex Inc.

HOLD

Current Price

$13.38

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.26

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERX
BCRX
Founded
1978
1986
Country
United States
United States
Employees
2100
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
VERX
BCRX
Price
$13.38
$8.26
Analyst Decision
Buy
Strong Buy
Analyst Count
12
11
Target Price
$24.25
$20.82
AVG Volume (30 Days)
1.2M
4.2M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
N/A
Revenue
$748,444,000.00
$25,186,000.00
Revenue This Year
$12.78
N/A
Revenue Next Year
$11.61
$12.55
P/E Ratio
$302.25
N/A
Revenue Growth
12.25
N/A
52 Week Low
$10.59
$6.00
52 Week High
$42.44
$11.31

Technical Indicators

Market Signals
Indicator
VERX
BCRX
Relative Strength Index (RSI) 52.70 37.55
Support Level $11.38 $7.94
Resistance Level $13.73 $8.68
Average True Range (ATR) 0.79 0.46
MACD -0.02 -0.08
Stochastic Oscillator 38.07 23.34

Price Performance

Historical Comparison
VERX
BCRX

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: